HLS Therapeutics Inc. (TSX:HLS)
3.940
-0.010 (-0.25%)
Sep 24, 2026, 4:00 PM EST
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 121.88 million as of September 24, 2026. Its market cap has decreased by -30.54% in one year.
Market Cap
121.88M
Enterprise Value
161.89M
Revenue
79.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.94
ChartMarket Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 121.88M, a decrease of -61.66%. That is a compound annual growth rate of -10.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 121.88M | -19.14% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Organigram Global | 221.38M |
| Cannara Biotech | 200.53M |
| BioSyent | 197.79M |
| Ascend Wellness Holdings | 168.72M |
| Medexus Pharmaceuticals | 163.10M |
| Grown Rogue International | 152.46M |
| Charlotte's Web Holdings | 118.01M |
| Leef Brands | 79.44M |